CHRiSS: Cardiac Health Risk Stratification System
CHRiSS:心脏健康风险分层系统
基本信息
- 批准号:8592756
- 负责人:
- 金额:$ 15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-15 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAdverse eventAlgorithmsAmericanBenefits and RisksBusinessesCardiacCaringClinicalCommunicationComputer softwareComputerized Medical RecordCost Effectiveness AnalysisCost SavingsDataDevelopmentDiagnosisEducationEvaluationEventFeasibility StudiesFoundationsGuidelinesHealthHealth Care CostsHealth systemHeart failureHeart-Assist DevicesHospitalsIncidenceInstitutionIntensive CareInterviewKnowledgeLeadLength of StayLifeLife StyleMachine LearningMarketingMedicalMedicareMethodsMetricMiningModelingNeeds AssessmentOutcomeOutpatientsPatientsPhasePostoperative PeriodPublic HealthQuality of lifeRiskSavingsSoftware ToolsStagingStratificationStructureSystemTechnologyTestingUpdateWorkcomputer human interactioncostdata miningdesigngraphical user interfaceimplantationimprovedmortalityoutcome forecastpatient populationpreferenceprognosticprogramsprototypepublic health relevancesatisfactionsuccesstooltrendusabilityventricular assist device
项目摘要
DESCRIPTION (provided by applicant): SUMMARY This project aims to produce and beta-test a clinical decision support application for end- stage heart failure, titled CHRiSS: Cardiac Health Risk Stratification System. It will be designed for patients with progressive heart failure who may eventually become candidates for ventricular assist device (VAD) therapy. The software will be build upon existing machine learning and data mining technology, developed by the PI and colleagues, designed to predict 90-day mortality following VAD implantation. This Phase- 1 effort will entail development of graphic user interfaces for both patients and clinicians
to incorporate personalized prognostic information into a functional decision-support utility. The inference algorithm will also be expanded to encompass adverse events, and risk of readmission. In this Phase-1 feasibility project, CHRiSS will be programmed and beta-tested at West Penn Allegheny Health System (WPAHS). This will entail semi- structured interviews to collect relevant expert knowledge, and mining the electronic medical records (EMR) to calibrate the prognostic algorithm to the institution-specific data. Successful completion of this Phase I project will lead to a multi-center trial in which the software is fully validated. Ultimate succes of this project will result in a software application that will optimize the benefit of VAD therapy to
public health, while reducing cost by reducing the unacceptably high rate of adverse events and unnecessary readmissions.
描述(由申请人提供):总结本项目旨在生产和测试终末期心力衰竭的临床决策支持应用程序,标题为CHRiSS:心脏健康风险分层系统。它将被设计用于患有进行性心力衰竭的患者,这些患者最终可能成为心室辅助装置(VAD)治疗的候选人。该软件将基于PI及其同事开发的现有机器学习和数据挖掘技术,旨在预测VAD植入后90天的死亡率。第一阶段的工作将需要为患者和临床医生开发图形用户界面
将个性化的预后信息纳入功能性决策支持工具。推理算法也将扩展到包括不良事件和再入院风险。在这个第一阶段的可行性项目中,CHRiSS将在西宾夕法尼亚州阿勒格尼卫生系统(WPAHS)进行编程和测试。这将需要半结构化访谈来收集相关的专家知识,并挖掘电子病历(EMR)来校准针对机构特定数据的预后算法。该I期项目的成功完成将导致多中心试验,其中软件得到充分验证。该项目的最终成功将产生一个软件应用程序,该软件应用程序将优化VAD治疗的益处,
公共卫生,同时通过降低不可接受的高不良事件率和不必要的再入院来降低成本。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES F. ANTAKI其他文献
JAMES F. ANTAKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES F. ANTAKI', 18)}}的其他基金
CORA_TM_A Personalized Cardiac Counselor for Optimal Therapy
CORA_TM_最佳治疗的个性化心脏咨询师
- 批准号:
9675403 - 财政年份:2018
- 资助金额:
$ 15万 - 项目类别:
Multiscale Model of Thrombosis in Artificial Circulation
人工循环血栓形成的多尺度模型
- 批准号:
9925233 - 财政年份:2018
- 资助金额:
$ 15万 - 项目类别:
CORA_TM_A Personalized Cardiac Counselor for Optimal Therapy
CORA_TM_最佳治疗的个性化心脏咨询师
- 批准号:
9199427 - 财政年份:2015
- 资助金额:
$ 15万 - 项目类别:
CORA_TM_A Personalized Cardiac Counselor for Optimal Therapy
CORA_TM_最佳治疗的个性化心脏咨询师
- 批准号:
8818809 - 财政年份:2015
- 资助金额:
$ 15万 - 项目类别:
CORA_TM_A Personalized Cardiac Counselor for Optimal Therapy
CORA_TM_最佳治疗的个性化心脏咨询师
- 批准号:
8995683 - 财政年份:2015
- 资助金额:
$ 15万 - 项目类别:
Blood Filtration System for the Treatment of Severe Malaria Patients
用于治疗重症疟疾患者的血液过滤系统
- 批准号:
8532028 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
Blood Filtration System for the Treatment of Severe Malaria Patients
用于治疗重症疟疾患者的血液过滤系统
- 批准号:
8393331 - 财政年份:2012
- 资助金额:
$ 15万 - 项目类别:
MULTI-SCALE MODEL OF THORMBOSIS IN ARTIFICIAL CIRCULATION
人工循环中血栓形成的多尺度模型
- 批准号:
7585083 - 财政年份:2009
- 资助金额:
$ 15万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 15万 - 项目类别:
Standard Grant